Clinical Trials in MENA

The Middle East and North Africa (MENA) region, with its rich cultural heritage and rapidly evolving healthcare landscape, is emerging as a significant player in the global clinical research arena. Home to over 400 million people, the region boasts a diverse population that presents unique opportunities for clinical trials. From the high prevalence of non-communicable diseases like diabetes and cardiovascular conditions to the growing investment in healthcare infrastructure, MENA is poised to become a key hub for medical research.

This book aims to provide a comprehensive exploration of clinical trials in MENA, highlighting the advantages, disadvantages, and unique characteristics of the region. By examining the current landscape, addressing key challenges, and envisioning the future, we hope to shed light on the transformative potential of clinical research in MENA. Whether you are a researcher, policymaker, or healthcare professional, this book will serve as a valuable resource for understanding and navigating the complexities of clinical trials in this dynamic region.